Monte Rosa Therapeutics, Inc. (GLUE)
17.75
-0.75
(-4.05%)
USD |
NASDAQ |
Feb 27, 16:00
17.76
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Shareholders Equity (Quarterly) : 245.84M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 274.24M |
| Pfizer Inc. | 86.48B |
| CorMedix, Inc. | 374.13M |
| Zoetis, Inc. | 3.331B |
| Alumis, Inc. | 384.77M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 459.84M |
| Total Liabilities (Quarterly) | 214.00M |
| Debt to Equity Ratio | 0.1634 |
| Current Ratio | 6.540 |
| Net Debt Paydown Yield | 0.18% |